Medela simplifies the delivery and management of Negative Pressure Wound Therapy (NPWT)

MCHENRY, IL. May 30, 2017 – Medela Healthcare announces the launch of the new Invia® FitPad™ Negative Pressure Wound Therapy dressing portfolio, making NPWT easier for healthcare professionals and patients. “With the launch of this versatile portfolio of devices and dressings, Medela’s new NPWT portfolio supports easier patient transitions from hospital to home. Our NPWT solutions are designed for ease-of-use by clinicians and patients”, states Dan Hyun, Vice President Medela Healthcare US.

NPWT from Medela helps reduce the clinical and administrative complexity of therapy. Medela`s Invia® Liberty™ and Invia® Motion™ systems include a new dynamic pressure management feature which helps ensure controlled and reliable negative pressure delivery at the wound site[1]. The new FitPad suction interface enables the dynamic measurement of pressure settings from the pump to the dressing site.

Medela provides a streamlined portfolio of both foam and gauze dressings. Invia Dressing Kits are available in a full range of sizes. All FitPad kits share the same adhesive transparent film, a low-profile FitPad suction interface and a Quick-connector for secure and convenient[2] tubing attachment. Medela NPWT Patients and their Caregivers can now have confidence in their therapy from pump to wound site.

The Invia® Motion™ completes the Medela portfolio, combining the convenience of a personal use system with the performance associated with a reusable pump. Invia Motion can be used in all patient care settings and assists with patient transitions throughout the continuum of care.

Around the web

California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue. 

The scam took place over a period of seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans. 

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.